Literature DB >> 14991390

Blood pressure and cardiovascular involvement in children with neurofibromatosis type1.

Giuliana Lama1, Luisa Graziano, Elvira Calabrese, Carolina Grassia, Pier Francesco Rambaldi, Fabrizio Cioce, Michele Adolfo Tedesco, Giovanni Di Salvo, Maria Esposito-Salsano.   

Abstract

We evaluated blood pressure in a sample of patients with neurofibromatosis type 1 (NF1), using ambulatory blood pressure monitoring (ABPM), to determine whether ABPM, when compared with casual BP recordings, allowed the detection of a higher risk for hypertension. We also evaluated the correlation between BP and vascular abnormalities. We studied 69 NF1 patients (36 males and 33 females) with a mean age of 11+/-4 years, divided into group A, with 24-h mean systolic blood pressure (SBP) or diastolic blood pressure (DBP) <95th percentile, and group B, with mean SBP or DBP >95th percentile. Standard electrocardiography and M-mode, two-dimensional echocardiography were performed and all patients were in sinus rhythm. ABPM identified 11 hypertensive patients (16%); 5 had a mean SBP >95th percentile, 3 mean SBP-DBP >95th percentile, and 3 a mean DBP >95th percentile. Laboratory and other investigations to exclude secondary hypertension were normal. Cardiac abnormalities were found in 13 of the 69 patients (18.8%) with NF1. There were no significant clinical and cardiac differences between the normotensive and hypertensive group. Our data emphasize the importance of periodic ABPM in NF1 patients to diagnose hypertension early and avoid target organ damage and increased mortality.

Entities:  

Mesh:

Year:  2004        PMID: 14991390     DOI: 10.1007/s00467-003-1397-5

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  39 in total

Review 1.  Neurofibromatosis type 1 in childhood.

Authors:  R Listernick; J Charrow
Journal:  J Pediatr       Date:  1990-06       Impact factor: 4.406

Review 2.  Type 1 neurofibromatosis and the pediatric patient.

Authors:  V M Riccardi
Journal:  Curr Probl Pediatr       Date:  1992-02

3.  A simple estimate of glomerular filtration rate in children derived from body length and plasma creatinine.

Authors:  G J Schwartz; G B Haycock; C M Edelmann; A Spitzer
Journal:  Pediatrics       Date:  1976-08       Impact factor: 7.124

4.  Update on the 1987 Task Force Report on High Blood Pressure in Children and Adolescents: a working group report from the National High Blood Pressure Education Program. National High Blood Pressure Education Program Working Group on Hypertension Control in Children and Adolescents.

Authors: 
Journal:  Pediatrics       Date:  1996-10       Impact factor: 7.124

Review 5.  Von Recklinghausen neurofibromatosis.

Authors:  V M Riccardi
Journal:  N Engl J Med       Date:  1981-12-31       Impact factor: 91.245

6.  Deletions and a translocation interrupt a cloned gene at the neurofibromatosis type 1 locus.

Authors:  D Viskochil; A M Buchberg; G Xu; R M Cawthon; J Stevens; R K Wolff; M Culver; J C Carey; N G Copeland; N A Jenkins
Journal:  Cell       Date:  1990-07-13       Impact factor: 41.582

7.  Cardiovascular malformations and other cardiovascular abnormalities in neurofibromatosis 1.

Authors:  A E Lin; P H Birch; B R Korf; R Tenconi; M Niimura; M Poyhonen; K Armfield Uhas; M Sigorini; R Virdis; C Romano; E Bonioli; P Wolkenstein; E K Pivnick; M Lawrence; J M Friedman
Journal:  Am J Med Genet       Date:  2000-11-13

8.  Hypertension and neurofibromatosis. Case report.

Authors:  G P Guthrie; P A Tibbs; R G McAllister; R K Stevens; D B Clark
Journal:  Hypertension       Date:  1982 Nov-Dec       Impact factor: 10.190

9.  Left ventricular mass and body size in normotensive children and adults: assessment of allometric relations and impact of overweight.

Authors:  G de Simone; S R Daniels; R B Devereux; R A Meyer; M J Roman; O de Divitiis; M H Alderman
Journal:  J Am Coll Cardiol       Date:  1992-11-01       Impact factor: 24.094

10.  Life expectancy, mortality and prognostic factors in neurofibromatosis type 1. A twelve-year follow-up of an epidemiological study in Göteborg, Sweden.

Authors:  M Zöller; B Rembeck; H O Akesson; L Angervall
Journal:  Acta Derm Venereol       Date:  1995-03       Impact factor: 4.437

View more
  13 in total

1.  High prevalence of elevated blood pressure among children with neurofibromatosis type 1.

Authors:  Tom Dubov; Hagit Toledano-Alhadef; Gil Chernin; Shlomi Constantini; Roxana Cleper; Shay Ben-Shachar
Journal:  Pediatr Nephrol       Date:  2015-08-28       Impact factor: 3.714

Review 2.  Pheochromocytoma in von Hippel-Lindau disease and neurofibromatosis type 1.

Authors:  Giuseppe Opocher; Pierantonio Conton; Francesca Schiavi; Beatrice Macino; Franco Mantero
Journal:  Fam Cancer       Date:  2005       Impact factor: 2.375

Review 3.  Aberrant Myeloid Differentiation Contributes to the Development of Osteoporosis in Neurofibromatosis Type 1.

Authors:  Steven D Rhodes; Feng-Chun Yang
Journal:  Curr Osteoporos Rep       Date:  2016-02       Impact factor: 5.096

Review 4.  Recent advances in RASopathies.

Authors:  Yoko Aoki; Tetsuya Niihori; Shin-ichi Inoue; Yoichi Matsubara
Journal:  J Hum Genet       Date:  2015-10-08       Impact factor: 3.172

5.  Heterozygous inactivation of the Nf1 gene in myeloid cells enhances neointima formation via a rosuvastatin-sensitive cellular pathway.

Authors:  Brian K Stansfield; Waylan K Bessler; Raghuveer Mali; Julie A Mund; Brandon Downing; Fang Li; Kara N Sarchet; Matthew R DiStasi; Simon J Conway; Reuben Kapur; David A Ingram
Journal:  Hum Mol Genet       Date:  2012-11-29       Impact factor: 6.150

Review 6.  Genetic information in the diagnosis and treatment of hypertension.

Authors:  Maciej Tomaszewski; Lukas Zimmerli; Fadi J Charchar; Anna F Dominiczak
Journal:  Curr Hypertens Rep       Date:  2006-08       Impact factor: 5.369

7.  Double NF1 inactivation affects adrenocortical function in NF1Prx1 mice and a human patient.

Authors:  Karolina Kobus; Daniela Hartl; Claus Eric Ott; Monika Osswald; Angela Huebner; Maja von der Hagen; Denise Emmerich; Jirko Kühnisch; Hans Morreau; Frederik J Hes; Victor F Mautner; Anja Harder; Sigrid Tinschert; Stefan Mundlos; Mateusz Kolanczyk
Journal:  PLoS One       Date:  2015-03-16       Impact factor: 3.240

Review 8.  The Use of Ambulatory Blood Pressure Monitoring As Standard of Care in Pediatrics.

Authors:  Caitlin G Peterson; Yosuke Miyashita
Journal:  Front Pediatr       Date:  2017-06-30       Impact factor: 3.418

9.  Arterial Stiffness in a Toddler with Neurofibromatosis Type 1 and Refractory Hypertension.

Authors:  Stella Stabouli; Euthymia Vargiami; Olga Maliachova; Nikoleta Printza; John Dotis; Maria Kyriazi; Konstantinos O Papazoglou; Dimitrios Zafeiriou
Journal:  Case Rep Pediatr       Date:  2018-10-31

Review 10.  At the bottom of the differential diagnosis list: unusual causes of pediatric hypertension.

Authors:  Matthew M Grinsell; Victoria F Norwood
Journal:  Pediatr Nephrol       Date:  2008-03-05       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.